Brainstorm Cell Therapeutics Inc. (BCLI)
Operating Cash Flow Growth
74.44%
Quarterly · Period ending:
BCLI Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported74.44%period ending
Latest reported74.44%period ending
BCLI Quarterly Cash from Operations YoY % (76.83% → 74.44%)
Year-over-year change
High-resolution chart · PNG
BCLI operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 74.4432% | |
| 19.0681% | |
| 29.3893% | |
| 66.5959% | |
| -108.0808% | |
| 46.7516% | |
| 68.0974% | |
| 48.5255% | |
| 75.1697% | |
| 23.156% | |
| 29.3244% | |
| -32.1443% | |
| -10.4989% | |
| -8.0803% | |
| 15.6137% | |
| 24.9226% | |
| -15.106% | |
| 58.876% | |
| 27.3159% | |
| 6.7013% | |
| 5.8813% | |
| 40.3287% | |
| -131.1775% | |
| -90.9542% | |
| -61.4025% | |
| -1,699.8802% | |
| 11.9527% | |
| 45.0106% | |
| -6,478.1818% | |
| 60.7244% | |
| -26.8484% | |
| -271.5847% | |
| 103.3742% | |
| -29.4762% | |
| -145.4013% | |
| 1,497.4545% | |
| -15.9317% | |
| 44.9178% | |
| 7.3586% | |
| 89.1304% | |
| 14.7879% | |
| -53.8978% | |
| 35.6751% | |
| -126.0947% | |
| -70.1031% | |
| -395.3964% | |
| -24.8134% | |
| -56.9425% | |
| 8.7488% | |
| 41.6418% | |
| -137.5185% | |
| 33.6127% | |
| -153.6993% | |
| 10.1877% | |
| -43.7367% | |
| -19.7324% | |
| 47.625% | |
| -1,256.3636% | |
| 13.894% | |
| -124.25% | |
| -52.381% | |
| 90.8027% | |
| -75.8842% | |
| -87.7934% | |
| -805.1724% | |
| -269.1358% | |
| -114.4828% | |
| 52.2422% | |
| 87.8407% | |
| 75.6757% | |
| 46.8864% | |
| 53.0032% | |
| -56.9409% | |
| -168.4791% | |
| -54.3192% | |
| -147.7542% | |
| 25.6806% | |
| 39.3426% | |
| 48.6808% | |
| -22.9003% | |
| -118.7684% | |
| -106.9128% | |
| 28.8192% | |
| -5,463.513% | |
| -1,311.4844% | |
| -2,735.6958% | |
| -9,705.3047% | |
| -77.3346% | |
| -3,498.913% | |
| -466.6667% | |
| -1,578.7425% | |
| 30.2341% | |
| 76.8262% |